We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+1.41%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2B
AUM Growth
-$231M
Cap. Flow
-$214M
Cap. Flow %
-10.69%
Top 10 Hldgs %
6.82%
Holding
1,904
New
580
Increased
368
Reduced
360
Closed
591

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$13.5M
2
AMGN icon
Amgen
AMGN
+$13.4M
3
CHTR icon
Charter Communications
CHTR
+$12M
4
AMZN icon
Amazon
AMZN
+$11M
5
CELG
Celgene Corp
CELG
+$10.9M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$20M
2
LNKD
LinkedIn Corporation
LNKD
+$19.3M
3
PFE icon
Pfizer
PFE
+$19.2M
4
ALKS icon
Alkermes
ALKS
+$14.8M
5
V icon
Visa
V
+$12.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.12%
2 Healthcare 11.46%
3 Technology 11.32%
4 Industrials 11.2%
5 Materials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAVB
1201
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$104K 0.01%
+9,891
New +$194K
OPCH icon
1202
Option Care Health
OPCH
$3.42B
$103K 0.01%
10,158
-15,646
-61% -$160K
NWY
1203
DELISTED
New York & Co Inc
NWY
$103K 0.01%
+69,592
New +$187K
WAC
1204
DELISTED
Walter Investment Mgt Corp
WAC
$103K 0.01%
+37,559
New +$203K
BSQR
1205
DELISTED
BSQUARE Corporation
BSQR
$103K 0.01%
18,488
-1,600
-8% -$9.14K
TNAV
1206
DELISTED
Telenav Inc.
TNAV
$102K 0.01%
20,026
-21,200
-51% -$111K
AXTI icon
1207
AXT Inc
AXTI
$3.13B
$101K 0.01%
+31,855
New +$97.9K
ENZ
1208
DELISTED
Enzo Biochem, Inc.
ENZ
$101K 0.01%
+17,061
New +$94.7K
ECYT
1209
DELISTED
Endocyte, Inc. Common Stock
ECYT
$97K ﹤0.01%
30,273
-63,700
-68% -$233K
VLTC
1210
DELISTED
Voltari Corporation
VLTC
$97K ﹤0.01%
+27,041
New +$99.9K
SZMK
1211
DELISTED
SIZMEK INC COM STK (DE)
SZMK
$97K ﹤0.01%
42,589
+10,000
+31% +$25.7K
RSYS
1212
DELISTED
Radisys Corp
RSYS
$96K ﹤0.01%
21,455
+7,200
+51% +$32.5K
CRMD icon
1213
CorMedix
CRMD
$596M
$94K ﹤0.01%
+9,454
New +$144K
GRBK icon
1214
Green Brick Partners
GRBK
$3.12B
$93K ﹤0.01%
+12,896
New +$94K
GNE icon
1215
Genie Energy
GNE
$378M
$91K ﹤0.01%
+13,519
New +$99.7K
CETV
1216
DELISTED
Central European Media Enterprises Ltd
CETV
$90K ﹤0.01%
42,712
+20,850
+95% +$51.8K
BLDP
1217
Ballard Power Systems
BLDP
$865M
$89K ﹤0.01%
71,888
+33,611
+88% +$46.6K
CPRX
1218
DELISTED
Catalyst Pharmaceutical
CPRX
$89K ﹤0.01%
126,289
-99,239
-44% -$79.9K
CAI
1219
DELISTED
CAI International, Inc.
CAI
$89K ﹤0.01%
+11,991
New +$102K
HYGS
1220
DELISTED
Hydrogenics Corp
HYGS
$88K ﹤0.01%
12,866
+1,592
+14% +$12.8K
DMK
1221
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$86K ﹤0.01%
+441
New +$203K
AUDC icon
1222
AudioCodes
AUDC
$249M
$85K ﹤0.01%
+20,456
New +$84.3K
GEN
1223
DELISTED
Genesis Healthcare, Inc.
GEN
$85K ﹤0.01%
48,350
-66,701
-58% -$136K
IMUX icon
1224
Immunic
IMUX
$188M
$84K ﹤0.01%
+34
New +$112K
NNVC icon
1225
NanoViricides
NNVC
$35.4M
$84K ﹤0.01%
+2,647
New +$96.6K
47 48
49
50 51

Similar funds

MA
MANA Advisors New York $3.06M AUM 7.13% 1-Year Est. Return
FFIM
Founders Fund III Management San Francisco, California $435K AUM
LC
Lunia Capital Dallas, Texas $4.49M AUM 42.82% 1-Year Est. Return
YEPV
Yorktown Energy Partners VI New York $6.21M AUM 74.4% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM

A.R.T. Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, A.R.T. Advisors held 1,904 positions worth $2B, down 10% from $2.24B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

A.R.T. Advisors withdrew a net $214M in Q2 2016, closing 591 positions and reducing 360 holdings. Its most notable exit was Johnson & Johnson, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

Against the trend, A.R.T. Advisors opened a new position in Mastercard worth $12.4M.

  • A.R.T. Advisors's largest Q2 2016 buy was Mastercard: 141,390 shares worth $12.4M.
  • A.R.T. Advisors added most to Paramount Global Class B in Q2 2016, an estimated $8.3M increase.
  • A.R.T. Advisors's biggest Q2 2016 reduction was Visa, cutting an estimated $12.8M.
  • A.R.T. Advisors fully exited Johnson & Johnson in Q2 2016, selling an estimated $20M.
  • A.R.T. Advisors's ten largest holdings make up 6.8% of its $2B portfolio in Q2 2016.
  • A.R.T. Advisors opened 580 new positions and closed 591 in Q2 2016.
  • A.R.T. Advisors's portfolio value fell 10% quarter-over-quarter to $2B.

Based on A.R.T. Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.